Publications by authors named "M Hoellwerth"

Claim this Profile
S
Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.
Katharina Schumann, Kai Christian Klespe, Cornelia Mauch, Carmen Loquai, Ulrike Schultheis, Magdalena Hoellwerth

J Eur Acad Dermatol Venereol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyelid nodule with persistent growth.
Magdalena Hoellwerth, Matthias Brandlmaier, Sylvia Selhofer, Martin Laimer, Peter Koelblinger

JAAD Case Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor-induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy-A multicentre analysis.
M Brandlmaier, M Hoellwerth, T Silly, C Hoeller, L Koch

J Eur Acad Dermatol Venereol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Approaches for Advanced Basal Cell Carcinoma: A Comprehensive Review.
Magdalena Hoellwerth, Matthias Brandlmaier, Peter Koelblinger

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blistering erythema on the right shoulder.
Matthias Brandlmaier, Magdalena Hoellwerth, Demetrios Papadopoulos, Peter Koelblinger

J Dtsch Dermatol Ges· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis